Acadia Healthcare Company, Inc. $ACHC Position Reduced by Raymond James Financial Inc.

Raymond James Financial Inc. cut its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 17.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 107,186 shares of the company's stock after selling 22,300 shares during the period. Raymond James Financial Inc. owned approximately 0.12% of Acadia Healthcare worth $3,250,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. GAMMA Investing LLC increased its holdings in shares of Acadia Healthcare by 143.8% during the first quarter. GAMMA Investing LLC now owns 5,812 shares of the company's stock valued at $176,000 after purchasing an additional 3,428 shares during the period. Envestnet Portfolio Solutions Inc. bought a new position in Acadia Healthcare in the 1st quarter valued at about $222,000. PNC Financial Services Group Inc. grew its position in Acadia Healthcare by 10.3% in the 1st quarter. PNC Financial Services Group Inc. now owns 6,672 shares of the company's stock valued at $202,000 after buying an additional 622 shares in the last quarter. Raiffeisen Bank International AG grew its position in Acadia Healthcare by 33.3% in the 1st quarter. Raiffeisen Bank International AG now owns 160,000 shares of the company's stock valued at $4,819,000 after buying an additional 40,000 shares in the last quarter. Finally, Teacher Retirement System of Texas bought a new position in Acadia Healthcare in the 1st quarter valued at about $412,000.

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC traded down $0.58 during trading hours on Friday, hitting $21.73. 2,150,271 shares of the company's stock traded hands, compared to its average volume of 2,287,824. Acadia Healthcare Company, Inc. has a 52 week low of $17.13 and a 52 week high of $79.82. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.32 and a current ratio of 1.32. The company's fifty day simple moving average is $22.09 and its two-hundred day simple moving average is $24.29. The company has a market cap of $2.01 billion, a price-to-earnings ratio of 14.39, a price-to-earnings-growth ratio of 4.39 and a beta of 0.89.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The company had revenue of $869.23 million during the quarter, compared to analyst estimates of $839.59 million. During the same quarter last year, the firm posted $0.91 EPS. The business's revenue for the quarter was up 9.2% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. As a group, equities analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the stock. Barclays decreased their target price on shares of Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating for the company in a research report on Thursday, August 7th. Mizuho decreased their target price on shares of Acadia Healthcare from $32.00 to $22.00 and set a "neutral" rating for the company in a research report on Wednesday, August 13th. Raymond James Financial reiterated an "outperform" rating and issued a $26.00 target price (down previously from $40.00) on shares of Acadia Healthcare in a research report on Thursday, August 14th. Stephens upgraded shares of Acadia Healthcare to a "hold" rating in a research report on Monday, June 2nd. Finally, Cowen restated a "buy" rating on shares of Acadia Healthcare in a research report on Thursday, August 7th. Eight equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Acadia Healthcare currently has a consensus rating of "Moderate Buy" and an average target price of $39.00.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.